Zscaler Q3 Miss Exposes Growth Stagnation, Thesis at Risk

What happened

Zscaler's Q3 FY26 results fell short of expectations, with organic revenue growth stagnating at 21% and FY27 guidance cut to 16-17%, confirming a structural slowdown in new enterprise wins. The company reported single-digit organic Net New ARR growth, as competitive pressures from integrated platforms and leadership departures weigh on pipeline and sales velocity. The DeepValue report's bullish thesis, which hinged on backlog visibility (RPO $6.05B) and operating leverage, is now undermined by deteriorating forward indicators. Despite a cheap valuation, the fundamental challenges—including platformization headwinds and churn from the Red Canary acquisition—suggest further downside risk. The narrative shifts from a sentiment-reset opportunity to a growth-at-risk story, demanding a cautious stance.

Implication

The structural growth deceleration and guidance cut erase the near-term upside case. Investors should monitor next quarter's RPO conversion, deferred revenue trends, and any stabilization in organic ARR growth. Only re-engage if forward coverage metrics re-accelerate above 20% YoY and GAAP operating losses narrow from -6% of revenue.

Thesis delta

The DeepValue report's 'POTENTIAL BUY' thesis, based on RPO visibility and non-GAAP leverage, is invalidated by Q3's confirmed organic growth stagnation and guidance cut. The stock's cheap valuation no longer compensates for deteriorating fundamentals, as competitive and execution risks mount. The thesis shifts from a sentiment-reset opportunity to a cautionary tale, with bear-case scenario ($100) becoming more probable.